Effects of cannabidiol on anandamide levels in individuals with cannabis use disorder: findings from a randomised clinical trial for the treatment of cannabis use disorder

Cannabidiol (CBD) has shown promise in treating psychiatric disorders, including cannabis use disorder – a major public health burden with no approved pharmacotherapies. However, the mechanisms through which CBD acts are poorly understood. One potential mechanism of CBD is increasing levels of anand...

Descripción completa

Detalles Bibliográficos
Autores principales: Hua, Daniel Ying-Heng, Hindocha, Chandni, Baio, Gianluca, Lees, Rachel, Shaban, Natacha, Morgan, Celia J., Mofeez, Ali, Curran, H. Valerie, Freeman, Tom P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10121552/
https://www.ncbi.nlm.nih.gov/pubmed/37085531
http://dx.doi.org/10.1038/s41398-023-02410-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10121552/
https://www.ncbi.nlm.nih.gov/pubmed/37085531
http://dx.doi.org/10.1038/s41398-023-02410-9

Ejemplares similares